Mucosal permeability and mast cells as targets for functional gastrointestinal disorders

被引:30
|
作者
Keita, Asa V. [1 ]
Soderholm, Johan D. [1 ,2 ]
机构
[1] Linkoping Univ, Div Surg Orthoped & Oncol, Dept Clin & Expt Med, Linkoping, Sweden
[2] Cty Council Ostergotland, Dept Surg, Linkoping, Sweden
基金
瑞典研究理事会;
关键词
IRRITABLE-BOWEL-SYNDROME; VASOACTIVE INTESTINAL POLYPEPTIDE; DILATED INTERCELLULAR SPACES; EPITHELIAL BARRIER; ABDOMINAL-PAIN; IMMUNE ACTIVATION; REFLUX DISEASE; COLONIC-MUCOSA; STRESS; MICROBIOTA;
D O I
10.1016/j.coph.2018.08.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The intestinal mucosa is constantly exposed to harmful lumina! content, and uptake is closely controlled and regulated by neuro-immune factors. If control is broken, it might lead to ongoing enhanced mucosal permeability, potentially resulting in functional gastrointestinal disorders. The importance of mast cells in the regulation of the mucosal barrier has become obvious, and increased numbers and more activated mast cells have been observed in irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease. To target the disturbed mucosal permeability, directly or via mast cells, is therefore currently of major interest. For example, administration of mast cell stabilizers and probiotics have shown promising effects in patients with functional gastrointestinal disorders.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 50 条
  • [1] Functional gastrointestinal disorders and mast cells: implications for therapy
    Barbara, G
    Stanghellini, V
    De Giorgio, R
    Corinaldesi, R
    NEUROGASTROENTEROLOGY AND MOTILITY, 2006, 18 (01): : 6 - 17
  • [2] Targeting mast cells in the treatment of functional gastrointestinal disorders
    Santos, Javier
    Alonso, Carmen
    Guilarte, Mar
    Vicario, Maria
    Ramon Malagelada, Juan
    CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (06) : 541 - 546
  • [3] RESERPINE AND GASTROINTESTINAL MUCOSAL MAST CELLS
    RASANEN, T
    TASINEN, E
    ACTA PHYSIOLOGICA SCANDINAVICA, 1966, 68 (3-4): : 360 - &
  • [4] Mast cells in gastrointestinal disorders
    Bischoff, Stephan C.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 778 : 139 - 145
  • [5] Role of mast cells in gastrointestinal mucosal defense
    Penissi, AB
    Rudolph, MI
    Piezzi, RS
    BIOCELL, 2003, 27 (02) : 163 - 172
  • [6] Serotonin, Eosinophils and Mast Cells in Functional Bowel Disorders: Regional Differences in the Gastrointestinal Tract
    Sandhu, Davinder K.
    Foxx-Orenstein, Amy E.
    Jensen, Kim L.
    Smyrk, Thomas C.
    Zinsmeister, Alan R.
    Walker, Marjorie M.
    Talley, Nicholas J.
    GASTROENTEROLOGY, 2009, 136 (05) : A787 - A787
  • [7] What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies?
    Panarelli, Nicole C.
    Hornick, Jason L.
    Yantiss, Rhonda K.
    MODERN PATHOLOGY, 2023, 36 (02)
  • [8] Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis?
    Siegert, SI
    Diebold, J
    Ludolph-Hauser, D
    Löhrs, U
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (04) : 560 - 565
  • [9] Mast cells as targets for glucocorticoids in the treatment of allergic disorders
    Kassel, O
    Cato, ACB
    RECENT ADVANCES IN GLUCOCORTICOID RECEPTOR ACTION, 2002, 40 : 153 - 176
  • [10] Symptoms of mast cell activation syndrome in functional gastrointestinal disorders
    Wilder-Smith, Clive H.
    Drewes, Asbjorn M.
    Materna, Andrea
    Olesen, Soren S.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (11) : 1322 - 1325